Botanical species · safety record

Cymbopogon winterianus

The EFSA Compendium of Botanicals holds 1 constituent measurement, 1 adverse-effect record and 1 genotoxicity assay for Cymbopogon winterianus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cymbopogon winterianus Jowitt ex Bor

1Constituent measurements

2Safety records

3Cited sources

11Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 11 licensed products naming Cymbopogon winterianus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Herb top

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(+)-pulegone	Unspecified	Essential oil	—	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Other toxicities	Neurologic: central nervous system	Leaves	Essential oil (as part-nature)	House mouse (as animal)	Short-term toxicity	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	DNA damage and/or repair	single cell gel/comet assay in mammalian cells for detection of DNA damage	Human (as organism)	No data	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Lorenzo, D., Paz, D., Loayza, I., Vila, R., Canigueral, S., Dellacassa, E. Enantiomeric analysis in the characterization and evaluation of aromatic plants. Ingenieria y ciencia quimica, 2002, p. 54-59.
Sinha, Sonali., Jothiramajayam, Manivannan., Ghosh, Manosij., Mukherjee, Anita. Evaluation of toxicity of essential oils palmarosa, citronella, lemongrass and vetiver in human lymphocytes. FOOD AND CHEMICAL TOXICOLOGY, 2014, vol. 68, p. 71-77. DOI
Leite, Barbara L. S., Souza, Thais T., Antoniolli, Angelo R., Guimaraes, Adriana G., Siqueira, Rosana S., Quintans, Jullyana S. S., Bonjardim, Leonardo R., Alves, Pericles B., Blank, Arie F., Botelho, Marco Antonio., Almeida, Jackson R. G. S., Lima, Julianeli T., Araujo, Adriano A. S., Quintans-Junior, Lucindo J. Volatile constituents and behavioral change induced by Cymbopogon winterianus leaf essential oil in rodents . African journal of biotechnology, 2011, vol. 10, no. 42, p. 8312-8319.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature